<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=1400074&amp;fmt=gif">

INVESTIGATOR CLINICAL RESEARCH

Advancing diagnostic data in lung disease

Working alongside academic and community-based investigators, we strive to advance lung disease research and produce the highest quality data to help inform the future of clinical practice.

We continuously seek to improve our data package for our commercial lung-focused diagnostic tests

Lung Nodule
Diagnosis

Nodify Lung™ consists of two blood-based proteomic tests (the Nodify CDT™ & Nodify XL2® tests) to help physicians reclassify risk of cancer and aid in stratifying patients into distinct nodule management pathways: intervention or surveillance.
nodifylung-654
 

Lung Cancer
Treatment Guidance

Biodesix Lung Reflex® testing consists of the GeneStrat® tumor profiling test and the VeriStrat® immune profiling test to provide physicians with timely molecular results to facilitate treatment decisions for patients with non-small cell lung cancer.

bdx-lung-logo
 

COVID-19 Diagnostic Testing

The Biodesix WorkSafe™ COVID-19 Testing Program consists of two EUA-FDA tests: the Bio-Rad SARS-CoV-2 ddPCR molecular test for active infection and the Platelia SARS-CoV-2 Total Antibody serology test for prior infection.

worksafe-logo

Interested in Partnering to Drive the Next Wave of Diagnostic Innovation?

We have multiple diagnostics in development addressing clinical questions in lung disease care.

To learn more about our diagnostic solutions, visit:

OUR DIAGNOSTICS IN DEVELOPMENT

Have a new research idea and need a diagnostic partner? Reach out to our team to begin a dialogue around your interests.

CONTACT OUR TEAM

If you are an investigator looking to explore clinical research studies using our commercial and pipeline diagnostic tests, please reach out to our Clinical Development & Medical Affairs Team

CONTACT OUR TEAM